These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25943467)

  • 1. Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study: methodological issues to avoid misinterpretation.
    Sabour S
    Blood Press Monit; 2015 Jun; 20(3):168. PubMed ID: 25943467
    [No Abstract]   [Full Text] [Related]  

  • 2. Response: Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study: methodological issues that strengthen our results.
    Estol CJ; Cotton D; Gorelick PB
    Blood Press Monit; 2015 Jun; 20(3):168-9. PubMed ID: 25943468
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study.
    Estol CJ; Bath PM; Gorelick PB; Cotton D; Martin RH; Weber MA; Dahlof B; ;
    Blood Press Monit; 2014 Oct; 19(5):256-62. PubMed ID: 24736279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of stroke in patients with hypertension.
    Dahlöf B
    Am J Cardiol; 2007 Aug; 100(3A):17J-24J. PubMed ID: 17666193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A third amlodipine/ARB combination (Twynsta) for hypertension.
    Med Lett Drugs Ther; 2010 Jan; 52(1329):2-3. PubMed ID: 20208469
    [No Abstract]   [Full Text] [Related]  

  • 7. Perindopril for improving cardiovascular events.
    DiNicolantonio JJ; O'Keefe JH
    Vasc Health Risk Manag; 2014; 10():539-48. PubMed ID: 25210459
    [No Abstract]   [Full Text] [Related]  

  • 8. Telmisartan to prevent recurrent stroke: the PRoFESS study: was the baby thrown out with the bathwater?
    McInnes GT
    Stroke; 2009 May; 40(5):1938-40. PubMed ID: 19038906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].
    MMW Fortschr Med; 2004 Aug; 146(33-34):52. PubMed ID: 15526635
    [No Abstract]   [Full Text] [Related]  

  • 10. Telmisartan provides superior BP reduction from morning to morning compared to other leading ARBs.
    Cardiovasc J S Afr; 2006; 17(4):210. PubMed ID: 17001428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of hypertension. Also pulse pressure must be reduced].
    MMW Fortschr Med; 2003 Sep; 145(37):65. PubMed ID: 14584451
    [No Abstract]   [Full Text] [Related]  

  • 12. [Normal blood pressure values in general practice are not enough. Also measure "morning after" values].
    MMW Fortschr Med; 2004 May; 146(19):62. PubMed ID: 15357487
    [No Abstract]   [Full Text] [Related]  

  • 13. PRoFESS.
    Lees KR
    Stroke; 2009 May; 40(5):1941. PubMed ID: 19038905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
    Chazova IE
    Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969
    [No Abstract]   [Full Text] [Related]  

  • 15. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
    Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
    Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there room for dual blockade of the renin-angiotensin-aldosterone system?
    Hollenberg NK
    J Hypertens; 2012 Apr; 30(4):671-2. PubMed ID: 22418900
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic approaches to antihypertensive treatment in diabetic patients.
    Cicero AF; Tocci G
    Hypertens Res; 2015 Dec; 38(12):802-3. PubMed ID: 26423788
    [No Abstract]   [Full Text] [Related]  

  • 18. A quest--halting the progression of autosomal dominant polycystic kidney disease.
    Ellison DH; Ingelfinger JR
    N Engl J Med; 2014 Dec; 371(24):2329-31. PubMed ID: 25399732
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].
    MMW Fortschr Med; 2007 Dec; 149(49-50):52-3. PubMed ID: 18236984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of antihypertensive effect of telmizartan in patients with hypertensive disease].
    Skavronskaia TV; Fedoseeva LA; Leus AI; Preobrazhenskiĭ DV
    Kardiologiia; 2005; 45(2):56. PubMed ID: 15798709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.